Citrullination of Epithelial Neutrophil–Activating Peptide 78/CXCL5 Results in Conversion From a Non–Monocyte‐Recruiting Chemokine to a Monocyte‐Recruiting Chemokine
Open Access
- 18 June 2014
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatology
- Vol. 66 (10) , 2716-2727
Abstract
Objective: To examine whether the citrullinated chemokines epithelial neutrophil–activating peptide 78 (ENA‐78)/CXCL5, macrophage inflammatory protein 1α/CCL3, and monocyte chemotactic protein 1/CCL2 are detected in the biologic fluid of patients with rheumatoid arthritis (RA), and if so, to determine the biologic activities of these chemokines.Methods: Recombinant human chemokines were citrullinated by peptidylarginine deiminase. Enzyme‐linked immunosorbent assays were performed to measure the concentrations of citrullinated chemokines in sera from patients with rheumatoid arthritis (RA) and normal individuals and in synovial fluid from patients with RA, patients with osteoarthritis (OA), and patients with other inflammatory rheumatic diseases. The correlation between the citrullinated chemokine levels and clinical data was analyzed. Monocyte and neutrophil chemotaxis assays were performed, and native (noncitrullinated) or citrullinated ENA‐78/CXCL5 was injected into mouse knees to evaluate the biologic activities of these chemokines.Results: The concentration of citrullinated ENA‐78/CXCL5 was significantly higher in RA sera and SF than in normal sera and in SF from patients with other rheumatic diseases including OA. In RA SF, a strong correlation between the amount of citrullinated ENA‐78/CXCL5 and the C‐reactive protein level or the erythrocyte sedimentation rate was observed. Citrullinated ENA‐78/CXCL5 induced monocyte chemotaxis via CXCR1 and CXCR2, while noncitrullinated ENA‐78/CXCL5 did not. In a mouse model of inflammatory arthritis, citrullinated ENA‐78/CXCL5 induced more severe inflammation and recruited more monocytes than did noncitrullinated ENA‐78/CXCL5.Conclusion: Citrullinated ENA‐78/CXCL5 is highly correlated with RA disease activity and, unlike noncitrullinated ENA‐78/CXCL5, recruits monocytes. These results indicate that citrullinated ENA‐78/CXCL5 may exert previously unrecognized inflammatory properties in RA by recruiting monocytes to inflamed joint tissue.Keywords
Funding Information
- Frederick G. L. Huetwell and William D. Robinson, MD Professorship in Rheumatology.
- Veterans Administration Research Service
This publication has 51 references indexed in Scilit:
- Citrullinated vimentin stimulates proliferation, pro-inflammatory cytokine secretion, and PADI4 and RANKL expression of fibroblast-like synoviocytes in rheumatoid arthritisScandinavian Journal of Rheumatology, 2012
- Identification and functional characterization of T cells reactive to citrullinated vimentin in HLA-DRB1*0401-positive humanized mice and rheumatoid arthritis patientsArthritis & Rheumatism, 2011
- Effect of posttranslational processing on the in vitro and in vivo activity of chemokinesExperimental Cell Research, 2011
- Posttranslational Modification of the NH2-terminal Region of CXCL5 by Proteases or Peptidylarginine Deiminases (PAD) Differently Affects Its Biological ActivityJournal of Biological Chemistry, 2010
- Expression and function of CXCL16 in a novel model of goutArthritis & Rheumatism, 2010
- Citrullinated vimentin as an important antigen in immune complexes from synovial fluid of rheumatoid arthritis patients with antibodies against citrullinated proteinsArthritis Research & Therapy, 2010
- Bacterial and human peptidylarginine deiminases: targets for inhibiting the autoimmune response in rheumatoid arthritis?Arthritis Research & Therapy, 2010
- Citrullination of CXCL8 increases this chemokine's ability to mobilize neutrophils into the blood circulationHaematologica, 2009
- Citrullination of CXCL8 by peptidylarginine deiminase alters receptor usage, prevents proteolysis, and dampens tissue inflammationJournal of Experimental Medicine, 2008
- Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritisArthritis & Rheumatism, 1995